Ascendis Pharma Bone Diseases A/s

This phase 3 trial tested a daily injection called TransCon PTH in 84 adults with hypoparathyroidism, a condition where the body lacks parathyroid hormone. For 26 weeks, some participants received the drug and others a placebo, without knowing which. The goal was to see if the dr…